Ftse Mib
32.908,05
0,74%
DAX
18.068,21
0,26%
S&P 500
5.473,23
0,77%
NASDAQ
17.857,02
0,95%
Bitcoin
65.623,61
-1,30%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Korro Bio Inc (KRRO) Korro Bio Inc (KRRO) Notizie

Korro Bio Inc

KRRO
34,72
-6,88 (-16,54%)
18 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
17/6/202422:27EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
17/6/202422:22EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
12/6/202423:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202422:05EDGAR2Form 8-K - Current report
05/6/202401:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202422:01GLOBEKorro to Participate in Upcoming June Investor and..
23/5/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
22/5/202422:37EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
20/5/202420:30GLOBEKorro Presents Additional Preclinical Data for KRRO-110 at..
15/5/202402:22EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/5/202422:34EDGAR2Form S-1 - General form for registration of securities under..
14/5/202422:20EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/5/202422:03EDGAR2Form 8-K - Current report
14/5/202422:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202422:02EDGAR2Form 8-K - Current report
14/5/202422:01GLOBEKorro Reports First Quarter 2024 Financial Results and..
18/4/202414:30GLOBEKorro Announces $70 Million Private Placement
01/4/202422:01GLOBEKorro to Participate in Upcoming Investor Conferences
26/3/202421:01GLOBEKorro Reports Full Year 2023 Financial Results and..
27/2/202414:00GLOBEKorro to Present at the TD Cowen 44th Annual Health Care..
18/1/202414:00GLOBEKorro Bio Highlights Data for its Lead Program in Alpha-1..
09/1/202415:02EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
09/1/202415:00EDGAR2Form 8-K - Current report
04/1/202414:00GLOBEKorro to Present at the 42nd Annual J.P. Morgan Healthcare..
22/12/202322:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
20/12/202322:44EDGAR2Form S-1/A - General form for registration of securities..
07/12/202314:00GLOBEKorro Announces Selection of its First Development Candidate..
01/12/202322:07EDGAR2Form S-1/A - General form for registration of securities..
29/11/202322:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202322:53EDGAR2Form 3 - Initial statement of beneficial ownership of..
29/11/202322:01EDGAR2Form 8-K - Current report
28/11/202314:00GLOBEKorro Bio Appoints Dr. Rachel Meyers to Board of Directors
28/11/202302:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202322:19EDGAR2Form 144 - Report of proposed sale of securities
22/11/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202321:25EDGAR2Form 144 - Report of proposed sale of securities
17/11/202322:23EDGAR2Form SC 13G - Statement of acquisition of beneficial..
17/11/202318:38EDGAR2Form SC 13D - General statement of acquisition of beneficial..
13/11/202322:15EDGAR2Form SC 13D - General statement of acquisition of beneficial..
13/11/202315:35EDGAR2Form 144 - Report of proposed sale of securities
13/11/202314:58EDGAR2Form 144 - Report of proposed sale of securities
13/11/202313:51EDGAR2Form 144 - Report of proposed sale of securities
08/11/202303:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202303:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202303:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202303:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202303:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202303:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/11/202303:02EDGAR2Form 3 - Initial statement of beneficial ownership of..
Apertura: 40,75 Min: 33,93 Max: 41,50
Chiusura: 41,60

La tua Cronologia

NASDAQ
KRRO
Korro Bio
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network